Management of primary Sjögren’s syndrome: recent developments and new classification criteria
出版年份 2018 全文链接
标题
Management of primary Sjögren’s syndrome: recent developments and new classification criteria
作者
关键词
-
出版物
Therapeutic Advances in Musculoskeletal Disease
Volume 10, Issue 2, Pages 39-54
出版商
SAGE Publications
发表日期
2018-01-01
DOI
10.1177/1759720x17746319
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
- (2017) Tim Both et al. International Journal of Medical Sciences
- Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain
- (2017) Steven E. Carsons et al. ARTHRITIS CARE & RESEARCH
- Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease
- (2017) Odilia B. J. Corneth et al. Arthritis & Rheumatology
- Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
- (2017) Simon J. Bowman et al. Arthritis & Rheumatology
- A7.07 Phosphatidylinositol 3–kinase delta pathway a novel therapeutic target for sjoegren's syndrome
- (2016) S Nayar et al. ANNALS OF THE RHEUMATIC DISEASES
- THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial
- (2016) L. Quartuccio et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
- (2016) Caroline H Shiboski et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies
- (2016) Raphaèle Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
- (2016) Benjamin A Fisher et al. ANNALS OF THE RHEUMATIC DISEASES
- Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers
- (2016) Andreas V. Goules et al. AUTOIMMUNITY REVIEWS
- Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study
- (2016) A. Alunno et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytokine-induced STAT1 activation is increased in patients with primary Sjögren's syndrome
- (2016) Marja Pertovaara et al. CLINICAL IMMUNOLOGY
- Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial
- (2016) Andrea Leonardi et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- A prospective evaluation of dental and periodontal status in patients with suspected Sjögren's syndrome
- (2016) Malo Le Gall et al. JOINT BONE SPINE
- Predicting the risk for lymphoma development in Sjogren syndrome
- (2016) Sofia Fragkioudaki et al. MEDICINE
- Treatment of primary Sjögren syndrome
- (2016) Alain Saraux et al. Nature Reviews Rheumatology
- 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts
- (2016) Caroline H. Shiboski et al. Arthritis & Rheumatology
- Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome
- (2016) G. Nocturne et al. Arthritis & Rheumatology
- The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus
- (2015) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
- (2015) Adrianos Nezos et al. JOURNAL OF AUTOIMMUNITY
- Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
- (2015) V Goede et al. LEUKEMIA
- Clinical Guidelines for Management of Dry Eye Associated with Sjögren Disease
- (2015) Gary N. Foulks et al. Ocular Surface
- IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs
- (2015) Francesca Barone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren’s syndrome
- (2015) Elena Pontarini et al. RHEUMATOLOGY
- Is salivary gland ultrasonography a useful tool in Sjögren’s syndrome? A systematic review
- (2015) Sandrine Jousse-Joulin et al. RHEUMATOLOGY
- Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations
- (2015) Theofanis Karageorgas et al. ARTHRITIS CARE & RESEARCH
- The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia
- (2015) A. Wiestner HAEMATOLOGICA
- Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome
- (2015) John C. Hall et al. Arthritis & Rheumatology
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
- (2014) P M Meiners et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
- (2014) Raphaèle Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients
- (2014) P Brito-Zerón et al. ANNALS OF THE RHEUMATIC DISEASES
- Selective JAK inhibitors in development for rheumatoid arthritis
- (2014) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- B-cell hyperactivity in primary Sjögren's syndrome
- (2014) Frans GM Kroese et al. Expert Review of Clinical Immunology
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tear Cathepsin S as a Candidate Biomarker for Sjögren's Syndrome
- (2014) Sarah F. Hamm-Alvarez et al. Arthritis & Rheumatology
- Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis
- (2013) E. William St.Clair et al. ARTHRITIS AND RHEUMATISM
- Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome
- (2013) Krisztina Szabo et al. CLINICAL IMMUNOLOGY
- Evaluation of Histologic, Serologic, and Clinical Changes in Response to Abatacept Treatment of Primary Sjögren's Syndrome: A Pilot Study
- (2013) Sabine Adler et al. ARTHRITIS CARE & RESEARCH
- Pain Severity and Neuropathic Pain Symptoms in Primary Sjögren's Syndrome: A Comparison Study of Seropositive and Seronegative Sjögren's Syndrome Patients
- (2013) Barbara M. Segal et al. ARTHRITIS CARE & RESEARCH
- Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
- (2013) Francesco Carubbi et al. ARTHRITIS RESEARCH & THERAPY
- Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
- (2012) Zana Brkic et al. ANNALS OF THE RHEUMATIC DISEASES
- Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
- (2012) P M Meiners et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
- (2012) Jacques-Eric Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
- (2012) Katrine Brække Norheim et al. PLoS One
- Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
- (2012) J. C. Hall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The B-lymphocyte stimulator connection in Sjogren's syndrome
- (2012) M. Ramos-Casals RHEUMATOLOGY
- BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands
- (2012) L. Quartuccio et al. RHEUMATOLOGY
- The Role of Ectopic Germinal Centers in the Immunopathology of Primary Sjögren's Syndrome: A Systematic Review
- (2012) Anna P. Risselada et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
- (2011) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome
- (2011) E. Theander et al. ANNALS OF THE RHEUMATIC DISEASES
- Classification criteria for Sjogren’s syndrome: A critical review
- (2011) Chiara Baldini et al. JOURNAL OF AUTOIMMUNITY
- Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
- (2011) Roy A Fava et al. ARTHRITIS RESEARCH & THERAPY
- Disturbance of cytokine networks in Sjögren's syndrome
- (2011) Pierre Youinou et al. ARTHRITIS RESEARCH & THERAPY
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial
- (2010) Frank P. Strietzel et al. ARTHRITIS AND RHEUMATISM
- Primary Sjögren’s syndrome activity and damage indices comparison
- (2010) Ana Campar et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
- (2009) J. Pijpe et al. ARTHRITIS AND RHEUMATISM
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
- (2009) Michael P. Cancro et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started